From October 1, 2022 to December 31, 2022, the company has repurchased 729,189 shares, representing 0.79% for CNY 50.54 million. With this, the company has completed the repurchase of 2,518,674 shares, representing 2.74% for CNY 150.01 million under the buyback announced on September 6, 2022.
Beijing Hotgen Biotech Co., Ltd.
Equities
688068
CNE100003P82
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.83 CNY | +0.43% |
|
-4.72% | -37.08% |
1st Jan change | Capi. | |
---|---|---|
-37.08% | 309M | |
-5.60% | 181B | |
-4.45% | 101B | |
-4.15% | 67.54B | |
-8.63% | 45.09B | |
+9.70% | 44.37B | |
+6.13% | 40.7B | |
+15.22% | 29.85B | |
+14.80% | 24.49B | |
-6.46% | 23.99B |
- Stock Market
- Equities
- 688068 Stock
- News Beijing Hotgen Biotech Co., Ltd.
- Tranche Update on Beijing Hotgen Biotech Co., Ltd.'s Equity Buyback Plan announced on September 6, 2022.